title: Prenatal hypoxia impairs the postnatal development of neural and functional chemoafferent pathway in rat.
abstract: 1. To define the effects of prenatal hypoxia on the postnatal development of the chemoafferent pathway, ventilation and metabolism, pregnant rats were exposed to normobaric hypoxia (10 % oxygen) from embryonic day 5 to embryonic day 20. Offspring were studied at 1, 3 and 9 weeks of age in three separate protocols. 2. Prenatal hypoxia decreased the dopamine content in the carotid bodies at all ages, and decreased the utilisation rate of noradrenaline in the caudal part of the A2 (A2c), A1 and A5 noradrenergic brainstem cell groups at 3 weeks after birth. At 9 weeks of age, the level of dopamine in the carotid bodies was still reduced but the utilisation rate of noradrenaline was enhanced in A1. 3. Rats from dams subjected to hypoxia during pregnancy hyperventilated until 3 weeks after birth. In these rats, the biphasic hypoxic ventilatory response was absent at 1 week and the increase in minute ventilation was amplified at 3 weeks. 4. Prenatal hypoxia disturbed the metabolism of offspring until 3 weeks after birth. A weak or absent hypometabolism in response to hypoxia was observed in these rats in contrast to control animals. 5. Prenatal hypoxia impairs the postnatal development of the chemoafferent pathway, as well as the ventilatory and metabolic responses to hypoxia. These alterations were mostly evident until 3 weeks after birth.
authors.affiliation: Laboratoire de Physiologie des Regulations Metaboliques, Cellulaires et Moleculaires, UMR CNRS 5578, Faculte de Medecine, 8 Avenue Rockefeller, 69 373 Lyon cedex 08, France. peyronne@rockefeller.univ-lyon1.fr
authors.forename: J
authors.initials: J
authors.lastname: Peyronnet
authors.forename: J C
authors.initials: JC
authors.lastname: Roux
authors.forename: A
authors.initials: A
authors.lastname: Geloën
authors.forename: L Q
authors.initials: LQ
authors.lastname: Tang
authors.forename: J M
authors.initials: JM
authors.lastname: Pequignot
authors.forename: H
authors.initials: H
authors.lastname: Lagercrantz
authors.forename: Y
authors.initials: Y
authors.lastname: Dalmaz
mesh_terms: D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000344:Afferent Pathways / Q000254:growth & development / Q000378:metabolism / Q000502:physiology; D000818:Animals; D001831:Body Temperature / Q000502:physiology; D001933:Brain Stem / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism; D002628:Chemoreceptor Cells / Q000378:metabolism / Q000502:physiology*; D004298:Dopamine / Q000378:metabolism; D005260:Female; D000860:Hypoxia / Q000378:metabolism / Q000503:physiopathology*; D009638:Norepinephrine / Q000378:metabolism; D009929:Organ Size / Q000502:physiology; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D012018:Reflex / Q000187:drug effects; D015656:Respiratory Mechanics / Q000502:physiology
chemical_list: D002395:Catecholamines; D015102:3,4-Dihydroxyphenylacetic Acid; D004298:Dopamine; D009638:Norepinephrine